Optimal treatment of retinal angiomatous proliferation.
Konstantinidis
Lazaros
L
Zografos
Leonidas
L
Mantel
Irmela
I
Ambresin
Aude
A
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000798:Angiomatosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab
Retina. 2009 Apr;29(4):536-44
19190547
Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1165-71
19404661